Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ligand Pharm (NQ: LGND )

142.62 USD +7.73 (+5.73%)
Official Closing Price Updated: 7:44 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ligand Pharm

< Previous 1 2 3 4 5 6 7 8 9
...
44 45 Next >
Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medicine Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer
Biopharmaceutical company is partnering with Sysmex Inostics to identify appropriate study candidates with the OncoBEAM™ ESR1 liquid biopsy test 
From GlobeNewswire News Releases
Implied MDY Analyst Target Price: $387
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Notable Thursday Option Activity: LGND, BYND, SCS
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ligand Pharmaceuticals Inc (LGND), where a total of 8,836 contracts have traded so far,... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For September 19, 2019
Upgrades Wells Fargo changed the rating for Cousins Properties Inc (NYSE: CUZ) from Market Perform to Outperform. For the second ... 
Tags DENN CUZ ATUS
From Benzinga
10 Biggest Price Target Changes For Thursday
JP Morgan raised Intelsat SA (NYSE: I) price target from $27 to $32. Intelsat shares closed at $22.91 on Wednesday. Macquarie cut ... 
Tags Benzinga TWLO Biotechnology
From Benzinga
Ligand Pharm Rising Today on Above-Average Volume (LGND)
Shares of Ligand Pharm are trading up 6.1% to $97.42 today on above average volume. About 435,000 shares have been traded today, as compared to the 30-day average volume... 
From Comtex SmarTrend® News Briefs
Notable Tuesday Option Activity: M, LGND, CMI
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Macy's Inc (M), where a total volume of 70,108 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Ligand Pharm Shares Down 24.8% Since SmarTrend's Sell Call (LGND)
SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 24.81% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
RSI Alert: Ligand Pharmaceuticals (LGND) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NXTC NEPH News
From Benzinga
Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in the H.C. Wainwright 21st Annual Global Investment Conference in New York City. Presentation... 
From Business Wire News Releases
Downtrend Call Working As Ligand Pharm Stock Falls 20.7% (LGND)
SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 20.71% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Look Under The Hood: EWMC Has 17% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Ligand Pharm Shares Down 19.9% Since SmarTrend's Sell Call (LGND)
SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 3 months, Ligand Pharm has returned 19.90% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
3 Top Biotech Stocks to Buy in August
In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares. 
Tags IQV AIMT LGND
From Motley Fool
Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and accelerating the launch of innovative... 
From Business Wire News Releases
The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit ... 
Tags MGEN ACER Biotech
From Benzinga
New 52-Week Lows For Monday Morning
Monday's morning session saw 648 companies set new 52-week lows. Areas of Interest: Industrial And Comml ... 
Tags COG AGIO ASRT
From Benzinga
Thursday 8/1 Insider Buying Report: LGND, TSLA
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their... 
Tags Stocks
From Market News Video
Watch for Continued Losses in Shares of Ligand Pharm (LGND)
Shares of Ligand Pharm (NASDAQ:LGND) traded today at $90.77, breaking its 52-week low. Approximately 130,000 shares have changed hands today, as compared to an average 30-day volume of 377,000... 
From Comtex SmarTrend® News Briefs
The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags GRFS AQST ABMD
From Benzinga
Ligand Pharm Has Returned 21.2% Since SmarTrend Recommendation (LGND)
SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 3 months, Ligand Pharm has returned 21.15% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
Proceeds will be used to fund Phase 2 ELAINE clinical trial, which is currently enrolling, to develop lasofoxifene as a potential precision medicine for metastatic breast cancer patients with ESR1... 
From GlobeNewswire News Releases
80 Biggest Movers From Yesterday
Gainers IRadimed Corporation (NASDAQ: IRMD) shares climbed 33.3% to close at $24.10 on Tuesday after the company posted upbeat Q2 ... 
Tags HCA CGNX Movers From Yesterday
From Benzinga
Ligand Pharmaceuticals Incorporated (LGND) Q2 2019 Earnings Call Transcript
LGND earnings call for the period ending June 30, 2019. 
Tags Market News LGND
From Motley Fool
Noteworthy Tuesday Option Activity: USAT, LGND, TAP
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in USA Technologies Inc (USAT), where a total of 3,799 contracts have traded so far,... 
Tags Stocks
From Market News Video
Long-Time Ligand Short Increases Position As Shares Fall 11% On Earnings
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) shares are down 10.5% on Tuesday following the company’s earnings report, but one of ... 
Tags Benzinga Emmanuel Lemelson PreMarket Prep
From Benzinga
58 Stocks Moving In Tuesday's Mid-Day Session
Gainers IRadimed Corporation (NASDAQ: IRMD) shares surged 21.7% to $22.00 after the company posted upbeat Q2 results and raised ... 
Tags Top Gainers AKS NBIX
From Benzinga
Oversold Conditions For Ligand Pharmaceuticals (LGND)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Lemelson Capital Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Calls on US Attorney to Investigate
As Ligand shares implode, reaching new multi-year low, Lemelson calls for intervention to protect investors 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
44 45 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.